PRESIDENCY
Paolo A. Ascierto
Christian U. Blank
Elizabeth M. Burton
FACULTY
LUCIA BENEDETTO*
Unit of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori – IRCCS – Fondazione “G. Pascale”, Naples, Italy
Luigi Buonaguro
Director Innovative Immunological Models Unit, National Cancer
Institute, IRCCS Fondazione “G. Pascale”, Naples, Italy
Tina Cascone
Associate Professor and Director of Translational Research Department of Thoracic/Head & Neck Medical Oncology; Regular Faculty Member, Immunology and Cancer Biology Programs Graduate School of Biomedical Sciences (GSBS) The University of Texas MD Anderson Cancer Center, Houston, TX, US
Myriam Chalabi
Medical Oncologist, GI cancers, Netherlands Cancer Institute,
Amsterdam, The Netherlands
GIUSEPPE CURIGLIANO
Full Professor of Medical Oncology, University of Milan; Head of the Clinical Division of Early Drug Development IEO Istituto Europeo di Oncologia, Milan
Michele Del Vecchio
Chief of Medical Oncology service SS Oncologia Medica Melanomi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Julie S. Deutsch
Assistant Professor Department of Dermatology, Johns HopkinsUniversity, Baltimore, MD, US
Alexander M. M. Eggermont
Chief Scientific Officer, Board of Directors, Princess Máxima Center;
Professor of Clinical&Translational Immunotherapy, Utrecht University,
Utrecht, The Netherlands
Leisha A. Emens
Professor of Medicine, Director of Translational Immunotherapy for the Women’s Cancer Research Center, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, UPMC Hillman Cancer Center/ Magee Women’s Hospital, Pittsburgh, PA, US
Corinne Faivre-Finn*
Professor of Cancer Biology, Departments of Surgical Oncology and
Cancer Biology, Medical Director, Melanoma and Skin Center, The
University of Texas, MD Anderson Cancer Center, Houston, TX, US
Gerardo Ferrara
Chief, Anatomic Pathology and Cytopathology Unit, Istituto Nazionale
Tumori IRCCS Fondazione ‘G. Pascale, Naples, Italy
LUCA FILIPPI
Nuclear Medicine Unit, Department of Oncohaematology, Fondazione PTV Policlinico Tor Vergata University Hospital, Rome, Italy
Jeffrey E. Gershenwald
Professor of Cancer Biology, Departments of Surgical Oncology and Cancer Biology, Medical Director, Melanoma and Skin Center, The University of Texas, MD Anderson Cancer Center, Houston, TX, US
Neil D. Gross
Professor, Department of Head and Neck Surgery, Division of Surgery Section Chief, Oropharynx Cancer, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX,US
John B.A.G. Haanen
Head of the Division of Medical Oncology; Leader of the research theme Immunotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands
Georgina V. Long
Co-medical Director , Chair of Melanoma Medical Oncology and Translational Research presso MIA e Royal North Shore Hospital, Melanoma Institute Australia, The University of Sydney, Wollstonecraft
NSW, Australia
ANTONIO NUCCIO*
Department of Medical Oncology, Università Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan, Italy
DAVID H. PENG*
Institute Senior Research Scientist, The University of Texas MD Anderson Cancer Center, Houston, TX, US
DIRK SCHADENDORF
Director & Chair, Department of Dermatology & Director, Comprehensive Cancer Center (Westdeutsches Tumorzentrum), University Hospital Essen
Janis Taube
Director, Division of Dermatopathology, Professor of Dermatology, Johns Hopkins University, School of Medicine, Baltimore, MD, US
HUSSEIN A. TAWBI
Professor; Deputy Chair, Department of Melanoma Medical Oncology Co-Director, Andrew M. McDougall Brain Metastasis Clinic & Program; Melanoma Medical Oncology; Investigational Cancer Therapeutics; UT MD Anderson Cancer Center, Houston, TX, US
Michael T. Tetzlaff
Professor of Pathology and Dermatology, Departments of Pathology
and Dermatology at The University of California, San Francisco, US
CLAUDIA TROJANIELLO
Medical Doctor, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Naples, Italy
MARIA GRAZIA VITALE
Medical Manager – SC Oncologia Clinica Sperimentale Melanoma, Immunoterapia e Terapie Innovative, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Naples, Italy
Jia Wu
Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, US
* to be confirmed